Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients.

MLA

Hirama, Takashi, et al. “Efficacy and Safety of MRNA SARS-CoV-2 Vaccines in Lung Transplant Recipients.” Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy, vol. 28, no. 8, Aug. 2022, pp. 1153–58. EBSCOhost, https://doi.org/10.1016/j.jiac.2022.04.019.

APA

Hirama, T., Akiba, M., Shundo, Y., Watanabe, T., Watanabe, Y., Oishi, H., Niikawa, H., & Okada, Y. (2022). Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy, 28(8), 1153–1158. https://doi.org/10.1016/j.jiac.2022.04.019

Chicago

Hirama, Takashi, Miki Akiba, Yuki Shundo, Tatsuaki Watanabe, Yui Watanabe, Hisashi Oishi, Hiromichi Niikawa, and Yoshinori Okada. 2022. “Efficacy and Safety of MRNA SARS-CoV-2 Vaccines in Lung Transplant Recipients.” Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy 28 (8): 1153–58. doi:10.1016/j.jiac.2022.04.019.